Leave a comment

26 European healthcare SMEs participate in a trade mission to Japan with bioXclusters plus

The European Strategic Cluster Partnership on Personalized Healthcare, bioXclusters plus – gathering Biocat (Catalonia), BioM (Bavaria), BioPmed (Piedmont) and Lyonbiopole (Auvergne Rhone-Alpes) – organizes in collaboration with the EU Japan Centre a mission to Japan from Oct 10th to 14th 2016. The mission will take place in Osaka and Yokohama.

The delegation is composed by the 4 clusters’ representatives along with 26 SMEs from the bioXclusters plus’ regions:

2bind GmbH, 4SC AG, Ability Pharmaceuticals S.L., Apceth GmbH & Co. KG, Ascenion GmbH, Bioindustry Park Silvano Fumero SpA, Boeters &LieckCoriolis Pharma Research GmbH, CTIBiotech, CYTOO SA, FGK Clinical Research GmbH, Gams Wellness, genOway, Indicia Production, Iris Biotech GmbH, Klifovet AG, Laboratorios Rubió S.A, Laboratorios Salvat S.A., Leukocare AG, Leukos Biotech, Medigene AG, Mind the Byte S.L., Novotec, Theranexus, Thrombotargets Europe S.L., Zeclinics S.L.

An agenda dedicated to SMEs and networking

The company delegation will benefit, on October 10th, from one training day dedicated to acquiring knowledge about the Japanese healthcare sector, organized in cooperation with the EU-Japan Centre. On October 11th, the delegation will participate in a dedicated “European Biotech & Pharma Partnering Conference” organized by bioXclusters plus at the Senri-Life Science Center in Osaka, with the support of Osaka Bio Headquarters and the EU Japan Centre.

On this occasion, more than 150 participants from Japanese and European life sciences and healthcare companies will have the opportunity to network and meet in face-to-face meetings. Around 330 meetings are planned. This unique event has been built up thanks to a growing collaboration between the bioXclusters plus’ partners and its Osaka counterparts.

In the last three days, the full delegation will join the Bio Japan Conference in Yokohama, where European companies will have new opportunities to meet with other Japanese players. The Bio Japan convention is one of the largest event on biotechnologies in Asia, offering multiple business opportunities for companies with around 800 companies participating each year. Moreover, bioXclusters plus will introduce the initiative to Japan during the Bio Cluster summit at Bio Japan, organized by the Japan Bioindustry Association (JBA) on October 13th.

Final agenda

Developing long term strategic partnerships with Japan

Japan is one of the markets targeted by the bioXclusters plus’ alliance. Japan has the 2nd largest global market in healthcare after the US. It is characterized by high health expenditures per capita, the use of advanced technology and a high level of R&D facilities supported by successive development plans of the government.

With an increasingly ageing population, biotechnologies and medical technologies solutions are playing a strategic role in the evolution of the societal and economic challenges advocated by the public authorities from Japan and the European Union in the next years. Moreover, over the past few years, the pharma and medtech industry in Japan have been more and more willing to foster collaborations with external players and in particular with Europe. These factors strongly reinforce the attractiveness of the market for European players in particular SMEs.

For this reason, the bioXclusters plus’ priority is to offer SMEs the right tools to approach such strategic markets by showcasing European competences through a unique delegation united under a single banner maximizing their visibility.

In the next months, the alliance intends to build up a “direct Gateway” based in Japan for its European SMEs to reinforce their market access and foster business relationships with a fast-track dimension.


Leave a comment

Updated information about the mission to Japan (Oct. 9th – 14th, 2016)

The European Strategic Cluster Partnership alliance on Personalised Healthcare, bioXclusters plus, which joins together four leading European BioClusters –BiocatBioMBioPmed and Lyonbiopole –, has organized a trade mission that will be heading to Japan this October. This visit is organized in cooperation with the EU-Japan Centre. The “Biotech Cluster SME Mission” and will take place from 9th to 14th October 2016.

The program includes workshops about the Japanese life science market and its regulation (10th October). A cultural visit is also planned so that participants gain a greater understanding of Japanese values and history. Continue reading

Leave a comment

European and Australian organisations sign international super cluster agreement

Six organisations representing life sciences and health clusters in Europe and Australia have signed a business development agreement today at the BIO International Convention 2016 in San Francisco. The agreement will help fast-track business results for companies and solve common problems faced by small-to-medium enterprises (SMEs) – entering new markets. Continue reading

1 Comment

Announcement of the mission to Japan (Oct. 9th – 14th, 2016)

The European Strategic Cluster Partnership alliance on Personalised Healthcare, bioXclusters plus, which joins together four leading European Bio Clusters – Biocat, BioM, BioPmed and Lyonbiopole – is pleased to invite European SMEs based in its regions to join its mission to Japan. This mission has been organised in the framework of BioJapan (Oct. 12 to 14, 2016). Continue reading

Leave a comment

The European Commission renews its support to the bioXclusters Alliance, “the European Strategic Cluster Partnership on Personalised Healthcare”

The European meta-cluster project bioXclusters plus (European Strategic Cluster Partnership on Personalised Healthcare) has been selected by the European Commission Executive Agency for Small and Medium-sized Entreprises (EASME) for the call for proposals COS-CLUSTER-2014-3-03 – Cluster Going International. Continue reading

Leave a comment

EU-Japan Cluster Matchmaking Event at BioEurope Report

The “EU‐Japan Cluster Matchmaking Event” was held at BIO‐Europe in Frankfurt, Germany, on 3rd November, 2014. Leading Japanese healtEU-Japan Fotoh care cluster representatives and their European counterparts met at this event to begin to build bridges between their organisations and to path the way for potential collaborations –as part of their goal to help SMEs find business partners. Continue reading

Leave a comment

EU-Japan Cluster Matchmaking Event at BioEurope – 3rd November 2014

The EU‐Japan Cluster Matchmaking Event – financially supported by the European Commission (http://www.clustercollaboration.eu) – is taking place at Bio Europe in Frankfurt (Germany) on November, 3rd. This event will provide the perfect opportunity for attendees to gain an overview of the strengths of Japanese life sciences and its clusters in the healthcare sector. Continue reading